JLABS @ NYC: Meet With… Pappas Capital
10:30 AM — 1:00 PM
Scott Weiner and Kyle Rasbach, Partners at Pappas Capital, will provide an overview of Pappas Capital’s investment strategy and meet one-on-one with pre-selected companies.
Since its founding in 1994, Pappas Capital has guided the launch and/or development of more than 70 life science companies, with a commitment to bringing promising products and technologies to market.
Scott Weiner and Kyle Rasbach, Partners at Pappas Capital, will be visiting JLABS @ NYC on Jan 31, 2018 to provide an overview of Pappas Capital’s investment strategy and meet one-on-one with pre-selected companies.
Pappas Capital invests exclusively in the life sciences sector – biotechnology, biopharmaceuticals, drug delivery, medical devices and related ventures – across the United States and Canada. The firm has raised more than $500 million across multiple funds, and has built a team with extensive experience in sourcing, evaluating, building and exiting life science companies. More than one-third of their 70 portfolio companies have successfully been acquired or completed initial public offerings.
New York Genome Center
101 Avenue of the Americas
(1st Floor Auditorium)
New York, NY 10013
10:30 AM | Registration Opens and Networking
11:00 AM | Presentation and Q&A
11:45 AM | Networking Lunch
1:00-5:00 PM | One-on-One Meetings*
*Companies must have applied for a one-on-one meeting ahead of time and been approved.
Applications are due January 17, 2018.
Presentation & Lunch
$25 | General Public
$35 | At the door
Includes presentation, Q&A, and lunch. All attendees must pay this fee, regardless of one-on-one meeting status.
Pre-registration to attend the presentation, Q&A, and lunch will remain open until noon on January 30th (or sold out).
FREE | Application
FREE | Accepted Companies
Companies must apply for a one-on-one meeting ahead of time. The one-on-one application period will close on January 17th, 2018. Your application will be reviewed and you will be notified of acceptance by January 26th, 2018. Acceptance of a one-on-one meeting is not guaranteed as all applications must be approved.
Kyle Rasbach, PhD | Partner, Pappas Capital
Kyle joined Pappas Capital in January 2018, bringing with him extensive experience in clinical pharmacology, basic science and healthcare equity research. Prior to joining Pappas, he was an equity research analyst and Vice President at T Rowe Price in Baltimore, where he managed pharmaceutical, specialty pharmaceutical and biotechnology investments for all T Rowe Price funds.
To learn more about Dr. Kyle Rasbach, click here.
Scott Weiner | Partner, Pappas Capital
Scott joined Pappas Capital in 2006, bringing with him a wide network and broad transaction experience. Prior to Pappas Capital, Scott was an investment manager and research analyst at Silverback Asset Management’s life science fund where he focused on healthcare securities investing.
To learn more about Mr. Scott Weiner, click here.
About the Meet With… Series:
The purpose of the Meet with Series events sponsored by JLABS is to help start-up entrepreneurs, as well as the academic community, connect with potential partners, such as big pharma or other investment corporations, through one-on-one meetings. It is also a chance for the featured corporation to outline their specific business development goals and clarify what types of products or research they are interested in and how best to approach them to get the partnering process started. Past participants include the Wellcome Trust, Bill & Melinda Gates Foundation, MedImmune Ventures, Mercury Fund, DARPA’s Biological Technologies Office, Correlation Ventures, Breakout Labs, New Enterprise Associates, Canaan Partners, Thomas McNerney & Partners, NCI, NCATS, NINDS, Allegory Venture Partners, Clarus Ventures, Johnson & Johnson Innovation, California Institute for Regenerative Medicine, Astellas Venture Management, and OrbiMed.
+FIVE POINTSFive Points lecture series bring leading scientists from around the world for an in-depth discussion of their work with students, researchers and clinicians from the New York Genome Center, its member institutions, and others in the medical/scientific community. While Five Points lectures are free and open to the general public, these lectures are most beneficial to scientists, clinicians and researchers who wish to accelerate their research through the use of DNA sequencing technology and bioinformatics. Five Points lectures often frame five or so key points, in a nod to the series’ name — followed by 15 minutes of Q&A, and 30 minutes of networking over hors d’oeuvres and cocktails. These afternoon events are held in the Center’s state-of-the-art ground-floor auditorium starting at 4 pm.
+EVENING TALKSThe New York Genome Center’s Evening Talks events feature distinguished experts from around the world sharing genomic insights and research. They are intended to showcase and explain high science to the non-scientific community. Speakers present the latest research findings and explain its implication for helping improve clinical care for a wide array of serious diseases. The lecture is followed by a lively question-and-answer session and a post-event reception of hors d’oeuvres and cocktails. These popular free public events are held in the Center’s state-of-the-art ground-floor auditorium starting at 6:30 pm. The Evening Talks Series is sponsored by The New York Community Trust – Pyewacket Fund.
+New York Cancer Genomics Research NetworkTo advance collaborative efforts on cancer genomics, the New York Genome Center (NYGC) hosts meetings on the first Tuesday of every month to bring together leading cancer researchers, clinicians and postdocs from the NYGC’s Institutional Founding Members and other key academic institutions. The organizers include Drs. Harold Varmus (Weill Cornell Medicine & NYGC), Marcin Imielinski (Weill Cornell Medicine & NYGC), Ross Levine (Memorial Sloan Kettering Cancer Center) and Sohail Tavazoie (The Rockefeller University).